- Home
- FGI vs XBIO Comparison
FGI vs XBIO Comparison
Compare FGI & XBIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | FGI | XBIO |
|---|---|---|
| Founded | 1987 | N/A |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Industrial Specialties | Biotechnology: Pharmaceutical Preparations |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 14.0M | 5.9M |
| IPO Year | 2022 | N/A |
Fundamental Metrics
Financial Performance| Metric | FGI | XBIO |
|---|---|---|
| Price | $6.03 | $2.41 |
| Analyst Decision | | Hold |
| Analyst Count | 0 | 1 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 59.2K | 47.3K |
| Earning Date | 11-14-2025 | 11-13-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $135,654,095.00 | $2,858,935.00 |
| Revenue This Year | $3.80 | $1.99 |
| Revenue Next Year | $6.26 | $20.00 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | 6.66 | ★ 13.30 |
| 52 Week Low | $2.28 | $2.20 |
| 52 Week High | $12.62 | $13.93 |
Technical Indicators
Market Signals| Indicator | FGI | XBIO |
|---|---|---|
| Relative Strength Index (RSI) | 48.81 | 40.78 |
| Support Level | $7.17 | $2.31 |
| Resistance Level | $9.00 | $2.64 |
| Average True Range (ATR) | 1.32 | 0.18 |
| MACD | 0.10 | 0.05 |
| Stochastic Oscillator | 22.21 | 31.65 |
Price Performance
Historical ComparisonAbout FGI FGI Industries Ltd.
FGI Industries Ltd is a supplier of kitchen and bath products. The company is business to business supplier of bath and kitchen products to large retail, wholesale, commercial, and specialty channel customers around the globe. The company offers products that fall into four categories: Sanitaryware, Bath Furniture, Shower Systems and Other. The company generates the majority of its revenue from the sale of Sanitaryware products. Geographically, the company generates the majority of its revenue from the United States, followed by Canada and Europe.
About XBIO Xenetic Biosciences Inc.
Xenetic Biosciences Inc is a biopharmaceutical company focused on advancing innovative immuno-oncology technologies addressing difficult to treat cancers. The company's DNase technology is designed to improve outcomes of existing treatments, including immunotherapies, by targeting neutrophil extracellular traps (NETs), which are involved in the progression of many human cancers. Xenetic is also focused on advancing its systemic DNase program into the clinic as an adjunctive therapy for pancreatic carcinoma and other locally metastatic solid tumors.